Companies: 10,795·Total market cap: $144.5T
Akerna Corp.

Akerna Corp.

KERNNASDAQHealthcare
$0.31
+$0.08(+36.94%)
Market Cap$162320
P/E Ratio
52W High$20.4
52W Low$0.25
Overview

Akerna Corp. (KERN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

kern · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Akerna Corp. (KERN) measures how much investors pay for each dollar of the company's trailing earnings. KERN's current PE ratio of N/A is calculated by dividing its stock price of $0.31 by its TTM earnings per share of -$0.08.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2025 est. EPS $-7.80
Based on 0 analysts
EPS (TTM)
-$0.08
TTM · diluted EPS
PEG Ratio
0.03
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Akerna Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2017 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Healthcare Information Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Akerna Corp.
Akerna Corp.You
KERN
$0MN/A-$0.08
Atlantic International Corp.
Atlantic International Corp.
ATLN
$66MN/A-$1.08
Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc.
BLPH
$0MN/A-$2.08
CareMax, Inc.
CareMax, Inc.
CMAX
$2MN/A-$183.30
Histogen Inc.
Histogen Inc.
HSTO
$0MN/A-$3.31
FSD Pharma Inc.
FSD Pharma Inc.
HUGE
$0MN/A-$0.47
MSP Recovery, Inc.
MSP Recovery, Inc.
MSPR
$0MN/A-$359.78

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.00
2024-12-31
FY2024
$-0.67
2022-12-31
FY2022
$-20.02
2021-12-31
FY2021
$-26.18
2020-06-30
FY2020
$-40.71
2018-12-31
FY2018
$-0.29
2017-12-31
FY2017
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Akerna Corp. (KERN) measures how much investors pay for each dollar of the company's trailing earnings. KERN's current PE ratio of N/A is calculated by dividing its stock price of $0.31 by its TTM earnings per share of -$0.08.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.31 ÷ -$0.08 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

KERN pe ratio · 6 questions

KERN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.31 and TTM EPS of -$0.08. Data sourced from Financial Modeling Prep via KERN's SEC 10-K and 10-Q filings.

KERN PE ratioWhat is KERN PE ratioCurrent PE ratio of KERNKERN PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Akerna Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09